We are live on ! Find out more
GPCM

Granite Point Capital Management Portfolio holdings

AUM $4.9M
1-Year Est. Return 38.41%
This Fund
S&P 500
This Quarter Est. Return
+6.69%
1 Year Est. Return
+38.41%
3 Year Est. Return
+124.67%
5 Year Est. Return
+295.96%
10 Year Est. Return
AUM
$140M
AUM Growth
-$464M
Cap. Flow
-$57.8M
Cap. Flow %
-41.33%
Top 10 Hldgs %
39%
Holding
136
New
34
Increased
13
Reduced
53
Closed
34

Sector Composition

Rank Sector Weight
1 Miscellaneous 31.55%
2 Healthcare 30.46%
3 Communication Services 9.96%
4 Consumer Discretionary 8.72%
5 Technology 8.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANGO icon
51
AngioDynamics
ANGO
$648M
$907K 0.65%
57,600
+47,600
+476% +$776K
PCRX icon
52
Pacira BioSciences
PCRX
$960M
$868K 0.62%
+12,400
New +$843K
GDX icon
53
VanEck Gold Miners ETF
GDX
$28.3B
$850K 0.61%
+36,000
New +$884K
EDU icon
54
New Oriental
EDU
$8.95B
$845K 0.6%
+28,800
New +$866K
RICE
55
DELISTED
Rice Energy Inc.
RICE
$818K 0.59%
+31,000
New +$754K
GME icon
56
GameStop
GME
$10.8B
$797K 0.57%
+77,600
New +$745K
ACTS
57
DELISTED
Actions Semiconductor Co
ACTS
$741K 0.53%
300,000
-103,072
-26% -$266K
TLPH icon
58
Talphera
TLPH
$61.8M
$735K 0.53%
3,060
-1,690
-36% -$400K
RNA
59
DELISTED
PROSENSA HLDGS N V ORD SHS (NLD)
RNA
$730K 0.52%
+129,600
New +$803K
ERNA icon
60
Eterna Therapeutics
ERNA
$4.76M
$729K 0.52%
1
-1
-50% -$490K
STE icon
61
Steris
STE
$20.5B
$716K 0.51%
+15,000
New +$702K
CEDU
62
DELISTED
CHINAEDU CORPORATION ADS
CEDU
$714K 0.51%
103,500
-103,757
-50% -$714K
TXMD icon
63
TherapeuticsMD
TXMD
$25M
$700K 0.5%
2,220
-2,580
-54% -$822K
LMAT icon
64
LeMaitre Vascular
LMAT
$1.84B
$695K 0.5%
86,105
-5,900
-6% -$47.2K
RVNC
65
DELISTED
Revance Therapeutics, Inc.
RVNC
$680K 0.49%
+21,600
New +$675K
STAA icon
66
STAAR Surgical
STAA
$1.13B
$677K 0.48%
36,000
-19,500
-35% -$314K
CBK
67
DELISTED
Christopher & Banks Corporation
CBK
$661K 0.47%
100,000
+9,412
+10% +$64.1K
PBYI icon
68
Puma Biotechnology
PBYI
$477M
$646K 0.46%
6,200
-3,800
-38% -$447K
QURE icon
69
uniQure
QURE
$2.99B
$622K 0.45%
+40,000
New +$638K
PCYC
70
DELISTED
PHARMACYCLICS INC
PCYC
$621K 0.44%
+6,200
New +$806K
WMGI
71
DELISTED
Wright Medical Group Inc
WMGI
$606K 0.43%
19,500
-10,500
-35% -$331K
DMK
72
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$591K 0.42%
1,329
-1,600
-55% -$726K
CELG
73
DELISTED
Celgene Corp
CELG
$586K 0.42%
8,400
-11,600
-58% -$919K
DYAX
74
DELISTED
DYAX CORPORATION
DYAX
$582K 0.42%
+64,800
New +$589K
KZ
75
DELISTED
KongZhong Corporation
KZ
$578K 0.41%
+50,400
New +$466K

Similar funds

Granite Point Capital Management's Q1 2014 Portfolio in Review

As of Q1 2014, Granite Point Capital Management held 136 positions worth $140M, down 77% from $603M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Granite Point Capital Management withdrew a net $57.8M in Q1 2014, closing 34 positions and reducing 53 holdings. Its most notable exit was RDA MICROELECTRONICS INC SPONSORED ADR, an estimated $6.05M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 32% of assets, down from 77% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Granite Point Capital Management opened a new position in Gentherm worth $3.5M.

  • Granite Point Capital Management's largest Q1 2014 buy was Gentherm: 100,800 shares worth $3.5M.
  • Granite Point Capital Management added most to China Distance Education Holdings Limited in Q1 2014, an estimated $2.29M increase.
  • Granite Point Capital Management's biggest Q1 2014 reduction was Himax Technologies, cutting an estimated $6.96M.
  • Granite Point Capital Management fully exited RDA MICROELECTRONICS INC SPONSORED ADR in Q1 2014, selling an estimated $6.05M.
  • Granite Point Capital Management's ten largest holdings make up 39% of its $140M portfolio in Q1 2014.
  • Granite Point Capital Management opened 34 new positions and closed 34 in Q1 2014.
  • Granite Point Capital Management's portfolio value fell 77% quarter-over-quarter to $140M.

Based on Granite Point Capital Management's 13F filing for Q1 2014, filed 14 May 2014.